ASND Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ascendis Pharma A/S

Watchlist Manager

Watchlist

Price: 263.59 USD 0.9% Market Closed

Market Cap: $16.4B

	Ascendis Pharma A/S NASDAQ:ASND	DK
	Los Andes Copper Ltd XTSX:LA	CA
	Wheaton Precious Metals Corp TSX:WPM	CA
	Edreams Odigeo SA OTC:EDEMY	ES
	IMCD NV AEX:IMCD	NL
K	Kandal M Venture Ltd NASDAQ:FMFC	KH
P	PagerDuty Inc F:2TY	US
F	FNS Holdings PCL SET:FNS	TH
S	Sterling Bancorp F:PVDA	US
	Fugro NV OTC:FUGRF	NL
	Brazilian Electric Power Co F:L3XA	BR
	Corsa Coal Corp XTSX:CSO	US
	Interparfums SA PAR:ITP	FR
P	Proto Script Pharmaceutical Corp OTC:PSCR	US
A	Aristocrat Leisure Ltd OTC:ARLUF	AU
F	Fortive Corp SWB:F03	US

Profitability Summary

Ascendis Pharma A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

91%

Strong 3Y Average Gross Margin

86%

Gross Margin is Increasing

80% > 91%

Healthy Operating Margin

25%

Negative 3Y Average Operating Margin

-91%

Operating Margin is Increasing

-484% > 25%

Exceptional Net Margin

71%

Negative 3Y Average Net Margin

-100%

Net Margin is Increasing

-511% > 71%

Exceptional Free Cash Flow Margin

32%

Negative 3Y Average Free Cash Flow Margin

-85%

Free Cash Flow Margin is Increasing

-461% > 32%

Exceptional ROE

119%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-60%

ROIC is Increasing

-205% > 216%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.